Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound Guided PRP for Post Traumatic Greater Occipital Neuralgia
NCT04051203Phase 1Completed
- Sponsor
- University of Calgary
- Start
- Feb 2019
- Primary completion
- Dec 2023
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Phase 1, randomised trial of autologous platelet-rich plasma in Occipital neuralgia (ON) (3 arms), sponsored by University of Calgary. Primary endpoints: Feasibility of platelet-rich plasma at 3 months and Safety profile of platelet-rich plasma at 3 months. Started Feb 2019; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
Occipital neuralgia (ON)
Beyond the preview
Go deeper on NCT04051203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04051203.